NM_001330574.2(ZNF711):c.2050A>G (p.Ser684Gly) AND Inborn genetic diseases
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Jul 25, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003364849.2
Allele description [Variation Report for NM_001330574.2(ZNF711):c.2050A>G (p.Ser684Gly)]
NM_001330574.2(ZNF711):c.2050A>G (p.Ser684Gly)
Condition(s)
- Name:
- Inborn genetic diseases
- Identifiers:
- MeSH: D030342; MedGen: C0950123
-
FERM domain (Protein4.1-ezrin-radixin-moesin) family [Caenorhabditis elegans]
FERM domain (Protein4.1-ezrin-radixin-moesin) family [Caenorhabditis elegans]gi|2506648041|ref|NP_001408267.1|Protein
-
Caenorhabditis elegans CYtochrome P450 family (cyp-33E2), mRNA
Caenorhabditis elegans CYtochrome P450 family (cyp-33E2), mRNAgi|1734330267|ref|NM_069069.5|Nucleotide
-
Caenorhabditis elegans CX domain-containing protein (F21C10.3), mRNA
Caenorhabditis elegans CX domain-containing protein (F21C10.3), mRNAgi|1972291002|ref|NM_171499.7|Nucleotide
-
PREDICTED: Gallus gallus vesicular, overexpressed in cancer, prosurvival protein...
PREDICTED: Gallus gallus vesicular, overexpressed in cancer, prosurvival protein 1 (VOPP1), transcript variant X10, mRNAgi|2201654420|ref|XM_025147590.3|Nucleotide
-
C2H2-type domain-containing protein [Caenorhabditis elegans]
C2H2-type domain-containing protein [Caenorhabditis elegans]gi|193207015|ref|NP_500587.2|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: May 1, 2024